about
Type 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy.Identification of BRCA1 As a Potential Biomarker for Insulin-Like Growth Factor-1 Receptor Targeted Therapy in Breast Cancer.IGF-IR signaling in epithelial to mesenchymal transition and targeting IGF-IR therapy: overview and new insightsInsulin-like Growth Factor 1 Receptor Expression in Advanced Non-small-cell Lung Cancer and its Impact on Overall Survival.The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer.Hyperglycaemia Induced by Novel Anticancer Agents: An Undesirable Complication or a Potential Therapeutic Opportunity?SUMO-modified insulin-like growth factor 1 receptor (IGF-1R) increases cell cycle progression and cell proliferation.IGF-1R inhibition sensitizes breast cancer cells to ATM-related kinase (ATR) inhibitor and cisplatin.Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38.Development of a 4-aminopyrazolo[3,4-d]pyrimidine-based dual IGF1R/Src inhibitor as a novel anticancer agent with minimal toxicity.Receptor tyrosine kinases and downstream pathways as druggable targets for cancer treatment: the current arsenal of inhibitors.The proximity-labeling technique BioID identifies sorting nexin 6 as a member of the insulin-like growth factor 1 (IGF1)-IGF1 receptor pathway.Targeting the IGF1R Pathway in Breast Cancer Using Antisense lncRNA-Mediated Promoter cis Competition.Combined RNA-seq and RAT-seq mapping of long noncoding RNAs in pluripotent reprogramming
P2860
Q33756414-C1AAA7E5-1B7A-498A-8BCF-8EBEF4B28381Q33849329-0D1EADAC-7296-41A4-9704-088DDEFA648AQ37615933-56EF3FDC-5C06-48F1-9A01-88526953D940Q38663388-32C4A8A0-C6C8-4A36-8F9C-9503D37052C1Q39028181-2CCDD0D0-46D0-4B02-9D98-F58A57CD2D92Q39040854-CEE776AA-1F90-4EBD-A8E3-CEDCD7FB1BD0Q41066789-E4EDA9DA-63F5-446A-8745-4F4518AD2968Q42322249-3D97308D-2016-4C45-909F-F93EE54F5180Q47105720-79CAEAA2-3423-4CB8-BCEA-D2E5E50A9C80Q49887912-8BE434B0-F01D-42F5-BB93-2EEB7043CCCEQ49887919-630A6860-B632-44B5-B2AE-90966187003AQ54121797-87D854A2-6A29-4670-B375-C3458EB1B776Q55438295-E9BD7667-D8E4-4901-AB31-F92C53D7D914Q59125184-6BC3C4A8-FD52-4466-83A6-33498AFB225B
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Minireview: Were the IGF Signaling Inhibitors All Bad?
@en
type
label
Minireview: Were the IGF Signaling Inhibitors All Bad?
@en
prefLabel
Minireview: Were the IGF Signaling Inhibitors All Bad?
@en
P2860
P356
P1476
Minireview: Were the IGF Signaling Inhibitors All Bad?
@en
P2093
Heather Beckwith
P2860
P304
P356
10.1210/ME.2015-1157
P50
P577
2015-09-14T00:00:00Z